CY1107530T1 - Παρασιτοκτονος συνθεση μακρας δρασης πepιεχουσα μια ενωση σαλικυλανιλιδιου, ενα πολυμepικο ειδος και τουλαχιστον μια αλλη αντιπαρασιτικη ενωση - Google Patents

Παρασιτοκτονος συνθεση μακρας δρασης πepιεχουσα μια ενωση σαλικυλανιλιδιου, ενα πολυμepικο ειδος και τουλαχιστον μια αλλη αντιπαρασιτικη ενωση

Info

Publication number
CY1107530T1
CY1107530T1 CY20071100037T CY071100037T CY1107530T1 CY 1107530 T1 CY1107530 T1 CY 1107530T1 CY 20071100037 T CY20071100037 T CY 20071100037T CY 071100037 T CY071100037 T CY 071100037T CY 1107530 T1 CY1107530 T1 CY 1107530T1
Authority
CY
Cyprus
Prior art keywords
salicylanilide
antiparasic
another
treatment
composition
Prior art date
Application number
CY20071100037T
Other languages
English (en)
Inventor
William Blakely
Lillian Cromie
Sean Duffy
Original Assignee
Norbrook Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Laboratories Limited filed Critical Norbrook Laboratories Limited
Publication of CY1107530T1 publication Critical patent/CY1107530T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Μια σύνθεση παρασκευαζόμενη για την αγωγή ζώων που πάσχουν από παράσιτα τα οποία παράσιτα είναι γνωστό ότι είναι επιδεκτικά σε τουλάχιστον μία από τις αβερμεκτίνες, μιλβεμυκίνες ή σαλικυλανιλίδια, περιέχουσα για παράδειγμα ιβερμεκτίνη σε μια ποσότητα από 0,1 έως 10% (w/v), ένα διαλύτη επιλεγμένο από την ομάδα που συνίσταται από φορμάλη γλυκερόλης, προπυλενογλυκόλη, πολυαιθυλενογλυκόλη και συνδυασμούς αυτών, και ένα σαλικυλανιλίδιο όπως closantel σε μια απαιτούμενη δοσολογική ποσότητα για το υπό αγωγή ζώο, τυπικώς περίπου 2,5 mg/kg ζωντανού βάρους του υπό αγωγή ζώου, ένα πολυμερικό είδος επιλεγμένο από την ομάδα που συνίσταται από πολυβινυλοπυρρολιδόνη και αδρομερή συμπολυμερή πολυοξυπροπυλενίου/πολυοξυαιθυλενίου, όπου τα ρηθέντα πολυμερικά είδη βελτιώνουν τη βιοδιαθεσιμότητα του closantel στο βαθμό που δύνανται να επιτευχθούν επίπεδα της ρηθείσας ένωσης στο πλάσμα αίματος μεγαλύτερα από περίπου 20 ppm κατά την περίοδο αγωγής.
CY20071100037T 2002-02-28 2007-01-10 Παρασιτοκτονος συνθεση μακρας δρασης πepιεχουσα μια ενωση σαλικυλανιλιδιου, ενα πολυμepικο ειδος και τουλαχιστον μια αλλη αντιπαρασιτικη ενωση CY1107530T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0204712A GB2386066A (en) 2002-02-28 2002-02-28 Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
EP03702765A EP1478372B1 (en) 2002-02-28 2003-02-12 Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound

Publications (1)

Publication Number Publication Date
CY1107530T1 true CY1107530T1 (el) 2013-03-13

Family

ID=9931978

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100037T CY1107530T1 (el) 2002-02-28 2007-01-10 Παρασιτοκτονος συνθεση μακρας δρασης πepιεχουσα μια ενωση σαλικυλανιλιδιου, ενα πολυμepικο ειδος και τουλαχιστον μια αλλη αντιπαρασιτικη ενωση

Country Status (23)

Country Link
US (1) US9289380B2 (el)
EP (1) EP1478372B1 (el)
JP (1) JP4480400B2 (el)
AP (1) AP1977A (el)
AR (1) AR038852A1 (el)
AT (1) ATE347897T1 (el)
AU (1) AU2003205887B2 (el)
BR (1) BR0307974B1 (el)
CA (1) CA2476520C (el)
CO (1) CO5611154A2 (el)
CR (1) CR7429A (el)
CY (1) CY1107530T1 (el)
DE (1) DE60310377T2 (el)
DK (1) DK1478372T3 (el)
EC (1) ECSP045320A (el)
ES (1) ES2275076T3 (el)
GB (1) GB2386066A (el)
MX (1) MXPA04007996A (el)
NZ (1) NZ534704A (el)
PT (1) PT1478372E (el)
SI (1) SI1478372T1 (el)
WO (1) WO2003072113A1 (el)
ZA (1) ZA200406782B (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
TW200505500A (en) * 2003-03-31 2005-02-16 Alza Corp Non-aqueous single phase vehicles and formulations utilizing such vehicles
US7666444B2 (en) 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
WO2006061214A1 (en) * 2004-12-10 2006-06-15 Bayer Healthcare Ag Anthelmintic composition
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
AU2007284759B2 (en) 2006-08-09 2010-10-28 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
RU2440097C2 (ru) 2007-04-23 2012-01-20 Интарсия Терапьютикс, Инк. Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
EP3735944A1 (en) 2009-09-28 2020-11-11 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
FR2991173B1 (fr) 2012-06-04 2015-11-06 Virbac Composition veterinaire a administration cutanee a base d'oxyclozanide
WO2015048371A1 (en) * 2013-09-30 2015-04-02 Zoetis Llc Long-acting spiro-isoxazoline formulations
MX2017003251A (es) 2014-09-12 2017-12-20 Antibiotx Aps Uso antibacteriano de salicilanilidas halogenadas.
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
MA44390A (fr) 2015-06-03 2019-01-23 Intarcia Therapeutics Inc Systèmes de mise en place et de retrait d'implant
GB201604484D0 (en) * 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
WO2017200943A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
IL267736B2 (en) 2017-01-03 2024-03-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
DE2263509C2 (de) 1972-12-27 1981-12-24 Rudolf Dr. 6380 Bad Homburg Kürner Deodorant
US4005218A (en) 1975-03-18 1977-01-25 Janssen Pharmaceutica N.V. Antiparasitic salicylanilide derivatives
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4206205A (en) 1977-10-03 1980-06-03 Merck & Co., Inc. Monosaccharide and aglycone derivatives of C-076
US4173571A (en) 1977-12-19 1979-11-06 Merck & Co., Inc. 13-Halo and 13-deoxy derivatives of C-076 compounds
US4171314A (en) 1977-12-19 1979-10-16 Merck & Co., Inc. 13-Halo and 13-deoxy C-076 compounds
US4128632A (en) * 1978-02-13 1978-12-05 Merck & Co., Inc. Solubilization of Rafoxanide
OA06863A (fr) 1980-08-04 1983-02-28 Merck & Co Inc Solubilisation de l'invermectine dans l'eau.
NZ210505A (en) 1983-12-22 1988-06-30 Merck & Co Inc Parasiticidal compositions containing avermectin or milbemycin derivatives
GB8727157D0 (en) * 1987-11-19 1987-12-23 Wellcome Found Pharmaceutical formulations
NZ223200A (en) * 1988-01-15 1989-01-06 Ancare Distributors Anthelmintic compositions containing 2',5-dicloro-4'-nitrosalicylanilide and non aqueous carrier
US5273805A (en) * 1991-08-05 1993-12-28 Minnesota Mining And Manufacturing Company Structured flexible carrier web with recess areas bearing a layer of silicone on predetermined surfaces
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
CN1054504C (zh) * 1993-03-15 2000-07-19 科尔加特·帕尔莫利弗公司 洁牙剂
PL174488B1 (pl) 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
EP0710105B1 (en) 1993-06-15 2003-07-30 The Australian National University Synergistic anthelmintic compositions against fasciola hepatica and other fasciola species
NZ248486A (en) * 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
WO1995016447A1 (en) * 1993-12-13 1995-06-22 Michael Hilary Burke Anthelmintic composition containing rafoxanide and fenbendazole
FR2739778B1 (fr) * 1995-10-13 1997-12-12 Virbac Lab Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US6193989B1 (en) * 1997-03-21 2001-02-27 Biogenesis S.A. Long acting injectable parasiticidal composition and the process for its preparation
US6340672B1 (en) 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
AUPQ875700A0 (en) 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions
AUPR510001A0 (en) * 2001-05-18 2001-06-14 Jupitar Pty Ltd Formulation and method

Also Published As

Publication number Publication date
EP1478372B1 (en) 2006-12-13
CA2476520C (en) 2009-08-11
GB2386066A (en) 2003-09-10
ES2275076T3 (es) 2007-06-01
AP1977A (en) 2009-03-19
GB0204712D0 (en) 2002-04-17
AU2003205887A1 (en) 2003-09-09
ZA200406782B (en) 2005-07-27
AU2003205887B2 (en) 2007-02-15
ECSP045320A (es) 2004-11-26
WO2003072113A1 (en) 2003-09-04
JP2005525355A (ja) 2005-08-25
AR038852A1 (es) 2005-01-26
JP4480400B2 (ja) 2010-06-16
CR7429A (es) 2006-02-06
BR0307974B1 (pt) 2014-10-21
BR0307974A (pt) 2004-12-21
US20050118221A1 (en) 2005-06-02
EP1478372A1 (en) 2004-11-24
DE60310377D1 (de) 2007-01-25
MXPA04007996A (es) 2004-11-26
CA2476520A1 (en) 2003-09-04
DK1478372T3 (da) 2007-04-10
NZ534704A (en) 2007-02-23
ATE347897T1 (de) 2007-01-15
CO5611154A2 (es) 2006-02-28
PT1478372E (pt) 2007-01-31
DE60310377T2 (de) 2007-10-31
US9289380B2 (en) 2016-03-22
AP2004003142A0 (en) 2004-09-30
SI1478372T1 (sl) 2007-04-30

Similar Documents

Publication Publication Date Title
CY1107530T1 (el) Παρασιτοκτονος συνθεση μακρας δρασης πepιεχουσα μια ενωση σαλικυλανιλιδιου, ενα πολυμepικο ειδος και τουλαχιστον μια αλλη αντιπαρασιτικη ενωση
CY1111923T1 (el) Παρασιτοκτονα σκευασματα
EA200602033A1 (ru) Пестицидные смеси
CY1108533T1 (el) Ανθελμινθικες στοματικες ομοιογενεις κτηνιατρικες παστες
CY1105000T1 (el) Χρηση της σπινοσαδης ή μιας συνθεσεως περιεχουσης σπινοσαδη
IL171587A (en) Composition of active substances with synergistic activity based on trifluorobutanyl compounds and insecticides
IL176059A0 (en) Active substance combinations having insecticidal properties
AR087990A2 (es) Combinaciones de compuestos activos, metodo para controlar composiciones fungicidas e insecticidas, uso de esas combinaciones o composiciones para controlar hongos e insectos, y procedimiento para la preparacion de esas composiciones
CY1105112T1 (el) Διαμορφωσεις δια καταπολεμησιν ανθρωπινων φθειρων, πepιεχουσαι σπινοσυνη (spinosyn)
CY1105221T1 (el) Ιατρικη χρηση θυρεοειδομιμητικων ενωσεων για την θepαπευτικη αγωγη της τριχοπτωσης και φαρμακευτικες συνθεσεις
BRPI0418098A (pt) formulações veterinárias não contendo produtos animais
BG50372A3 (en) Fungicidal composition a method of combating fungus
ECSP066360A (es) Composición parasiticida
AU2641501A (en) Sustained-release compositions for parenteral administration
ATE279105T1 (de) Pestizide zusammensetzung
AR027688A1 (es) Acilsulfimidas heterociclicas, procedimiento para su preparacion, agentes que las contienen y su empleo como agentes para combatir animales perjudiciales
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
BRPI0513502A (pt) inseticidas e/ou acaricidas seletivos à base de compostos dicarbonila cìclicos, substituìdos e protetores
AR038853A1 (es) Una composicion parasiticida inyectable
RU2001130762A (ru) Композиция фипронила, обогащенная (s)-энантиомером
DE69911204D1 (de) Bekämpfung von parasitischen befallen in fischen
AR000734A1 (es) Composicion herbicida selectiva y un proceso para el control selectivo de malezas de hoja ancha y hierbas en cultivos de plantas utiles.
AR026523A1 (es) Uso de compuestos paa el tratamiento transdermico de infecciones bacterianas
DE60104115D1 (de) Zusammensetzung mit verzögerter freisetzung enthaltend einen wirkstoff in einem plastischen träger sowie daraus hergestellte formkörper
ATE152879T1 (de) Antiparasitäre zusammensetzung zur verwendung bei tieren